SET2 is a selective TRPV2 antagonist (IC50=0.46 µM). SET2 blocks the TRP channel and suppresses prostate cancer cells migration. SET2 reduces the lysophosphatidic acid (LPA, a TRPV2 activator)-induced cytoplasmic calcium increases.
Molecular Weight:
402.43
Purity:
99.0%
CAS Number:
[2313525-20-9]
Formula:
C17H21F3N4O2S
Target:
TRP Channel
* VAT and and shipping costs not included. Errors and price changes excepted
